The effect of symptomatic extra-articular manifestations of rheumatoid arthritis on disease activity and patient-reported outcomes: a cross-sectional and observational study

Advances in Rheumatology · Published 2026-07-25 · DOI 10.1186/s42358-026-00569-5

Free full text

Authors (6)

Ahmet Oruç, Hasan Satış, Merve Oruç, Reyhan Bilici, Abdurrahman Tufan, Mehmet Akif Öztürk

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Oruç, A., Satış, H., Oruç, M., et al. (2026). The effect of symptomatic extra-articular manifestations of rheumatoid arthritis on disease activity and patient-reported outcomes: a cross-sectional and observational study. Advances in Rheumatology. https://doi.org/10.1186/s42358-026-00569-5

Related articles

• Psychosocial and behavioral correlates of persistent pain post disease-modifying treatment change in rheumatoid arthritis: a 12-month cohort study · Advances in Rheumatology · 2026 · Same journal
• Comparative analysis of conventional and novel inflammatory biomarkers in Familial Mediterranean fever during attack-free periods · Advances in Rheumatology · 2025 · Same journal
• Correlation between body mass index and disease activity in patients with systemic lupus erythematosus from China · Advances in Rheumatology · 2025 · Same journal
• Exploring somatosensory temporal discrimination deficits in rheumatoid arthritis: associations with disease activity and functionality · Advances in Rheumatology · 2025 · Same journal
• Brazilian Society of Rheumatology – 2025 recommendations on vaccination in immune-mediated rheumatic diseases · Advances in Rheumatology · 2026 · Same journal
• Comparison of the immunogenicity and safety among COVID-19 vaccines ChadOx-1, CoronaVac and BNT162b2 in systemic lupus erythematosus (SLE) patients: a prospective cohort · Advances in Rheumatology · 2025 · Same journal
• Hyperinflammatory status associated with COVID-19: clinical features of a pediatric series · Advances in Rheumatology · 2025 · Same journal
• Brazilian Society of Rheumatology’s fibromyalgia treatment guidelines – part I: monitoring and non-pharmacological management · Advances in Rheumatology · 2026 · Same journal
• Are global definitions enough? Revisiting CDAI and SDAI remission cut-offs in Brazilian Rheumatoid Arthritis patients · Advances in Rheumatology · 2026 · Same journal
• Vascular endothelial growth factor (VEGF) biology and its proposed role in rheumatic diseases pathogenesis · Advances in Rheumatology · 2026 · Same journal